Equine Genetics Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The global equine genetics market was valued at $377.2 million in 2025 and is forecast to reach approximately $686.6 million by 2033, expanding at a CAGR of 7.9%. The market comprises genetic testing services, genomic screening products, and related technologies used primarily for parentage verification, inherited disease detection, and performance-trait identification in horses. It represents a specialized segment within the broader animal genetics industry, which was valued between $7.8 billion and $8.9 billion in 2025 depending on the source.

• •No government or official statistical agency publishes dedicated market-size figures for equine genetics; industry estimates are compiled by private research firms
• •The horse DNA testing market, broader in scope, was valued at $1.8 billion in 2025 and projected to reach $3.6 billion by 2034 at 8.1% CAGR
• •The related equine artificial insemination market was valued at approximately $648 million in 2025, growing at roughly 5.9% CAGR

A primary growth engine is the expanding use of genetic testing for parentage verification and identification of heritable diseases in breeding programs, particularly among Thoroughbred, Warmblood, and Arabian breeders who require documented pedigree accuracy. Advances in equine genomic research have made SNP-based testing more affordable and accessible, encouraging adoption beyond elite studs to commercial and recreational breeding operations. Additionally, growing awareness of genetic disorders such as HYPP, HERDA, and GBED has prompted breed registries and owners to mandate or strongly recommend genetic screening.

• •Breed registries increasingly mandate or recommend genetic testing for disease mutations and coat color traits
• •Rising investment in equine genomic research has accelerated the discovery of new genetic markers linked to performance and health
• •Equestrian sports and the commercial breeding industry's growth, particularly in North America and Europe, fuel demand for genetic services

The market is typically segmented by type, including DNA profiling, genetic disease testing, and parentage verification, and by application across breeding programs, veterinary diagnostics, and research. Geographically, North America and Europe dominate market share due to mature equine industries, well-established breed registries, and high awareness of genetic testing benefits. The Asia-Pacific region is expected to see the fastest growth as equestrian sports gain popularity and veterinary infrastructure expands in countries such as China, India, and Australia.

• •North America leads in market revenue due to large Thoroughbred and Quarter Horse breeding industries and widespread veterinary access to genetic testing
• •Europe holds a significant share, particularly in Warmblood breeding nations such as Germany, the Netherlands, and Belgium
• •Asia-Pacific is the fastest-growing region, driven by rising participation in equestrian sports and increasing veterinary spending

What are the recent trends and outlook?

The market is moving toward whole-genome sequencing and expanded SNP panels that can simultaneously assess thousands of genetic markers for health, conformation, and performance traits. Integration of genetic testing data into digital breeding management platforms is becoming increasingly common, allowing breeders to make data-driven mating decisions. Emerging research into equine complex traits, such as gait, temperament, and athletic potential, is expected to open new application areas. By 2033, the market is anticipated to approach $686.6 million, with continued growth supported by declining sequencing costs, expanding test menus, and growing global equine populations.

• •Next-generation sequencing and whole-genome analysis are gradually replacing single-marker tests, offering more comprehensive genetic profiles
• •Digital platforms that integrate genetic data with pedigree and performance records are gaining traction among professional breeders
• •Research into novel genetic markers for traits such as disease resistance and endurance capacity is expected to broaden the market's application scope